DEGREE OF METABOLIC DYSFUNCTION IS LINKED TO STEATOHEPATITIS (MASH), FIBROSIS, AND HIGHER CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

被引：0
|
作者：
Kim, David [1 ]
Abboud, Yazan [1 ]
Ismail, Mohamed [1 ]
Goyal, Ritik Mahaveer [1 ]
Pyrsopoulos, Nikolaos [1 ]
Kim, Hyunseok [2 ]
Hajifathalian, Kaveh [1 ]
Al-Khazraji, Ahmed [1 ]
机构：
[1] Rutgers New Jersey Med Sch, Newark, NJ USA
[2] Baylor Coll Med, Houston, TX 77030 USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
602
引用
收藏
页码：S441 / S442
页数：2
相关论文
共 50 条
  • [41] Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Markowska, Julia
    Kasprzak-Drozd, Kamila
    Nizinski, Przemyslaw
    Dragan, Magdalena
    Kondracka, Adrianna
    Gondek, Ewa
    Oniszczuk, Tomasz
    Oniszczuk, Anna
    MOLECULES, 2024, 29 (22):
  • [42] Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Elshaer, Amani
    Chascsa, David M. H.
    Lizaola-Mayo, Blanca C.
    LIFE-BASEL, 2024, 14 (07):
  • [43] Metabolic dysfunction-associated steatotic liver disease and low handgrip strength are independently associated with a higher risk for cardiovascular disease
    Kim, Seung Up
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Mi Na
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    JOURNAL OF HEPATOLOGY, 2024, 80 : S498 - S498
  • [44] Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
    Chan, Wah-Kheong
    Chuah, Kee-Huat
    Rajaram, Ruveena Bhavani
    Lim, Lee-Ling
    Ratnasingam, Jeyakantha
    Vethakkan, Shireene Ratna
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (03) : 197 - 213
  • [45] EATING DISORDERS IN MEXICAN POPULATION WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Contreras, Ana D. Cano
    Alvarez, Hector Ricardo Ordaz
    Priego-Parra, Bryan Adrian
    Martinez-Perez, Genesis Patricia
    Reyes-Diaz, Sara A.
    Azamar, Pamela Duran
    Garcia-Carvajal, Mario J.
    Diaz-Crespo, Angel H.
    Vazquez-Cruz, Anette P.
    Hernandez, Tonatiu Castellanos
    Basurto, Jose Luis Vargas
    Dietlen, Federico B. Roesch
    Francisco, Maria D.
    Amieva-Balmori, Mercedes
    Remes-Troche, Jose Maria
    GASTROENTEROLOGY, 2024, 166 (05) : S1649 - S1650
  • [46] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis
    Saidi, A. N.
    Theel, W. B.
    Burggraaf, B.
    van der Lelij, A. J.
    Grobbee, D. E.
    van Zeben, J. D.
    van der Zwan-van Beek, E.
    Rauh, S. P.
    Cabezas, M. Castro
    CLINICAL RHEUMATOLOGY, 2025, : 1485 - 1492
  • [47] Evaluation of a Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Clinical Pharmacy Service
    Sallam, Sandy
    Ahmed, Aijaz
    Gu, Xin
    DIABETES, 2024, 73
  • [48] ALTERED GUT VIRAL ECOLOGY IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Nzabarushimana, Etienne
    Kim, Hanseul
    Jensen, Jordan
    Shen, Jiaxian
    Nelson, Paul
    Thompson, Kelsey N.
    Chan, Andrew T.
    Hayete, Boris
    Huttenhower, Curtis
    Nguyen, Long H.
    GASTROENTEROLOGY, 2024, 166 (05) : S1539 - S1540
  • [49] Clarifications and enhancements for cardiovascular risk study in metabolic dysfunction-associated steatotic liver disease
    Wu, Yinfang
    Xu, Weixing
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2025, 132 : 158 - 159
  • [50] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
12345